News

Clinically Inspired Gut-Skin Axis Supplement Prime Biome Faces Real Consumer Feedback and Scientific Scrutiny—Here’s What the ...
Glutathione works by inhibiting the enzyme tyrosinase, which is responsible for melanin production. Reduced melanin levels result in a brighter and more even skin tone over time. This property makes ...
Rifai is focused on enhancing the overall lifestyle of its clients. The fun and creative packaging reinforces the idea that ...
Basis EHR established its first MVP release which subsequently made the system a preference among clinicians thus surpassing ...
Pursuant to the existing sales agreement entered into by the Company on December 22, 2022, ATM Shares may be sold from time to time at a sales price per ATM Share equal to prevailing USD market prices ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
Approving this extension of the maturity of the CB 2025 until September 17, 2025 is the first step in a larger holistic restructuring to provide the time required for its implementation, as announced ...
Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD).
Ipsen is confirming financial guidance for full-year 2025: Total sales growth greater than 5.0%, at constant currency. Based on the average level of exchange rates in March 2025, a limited effect on ...
Dr. Moses Haregewoyn leads Automated Health Systems, which uses technology and structured management to expand access to public healthcare for individuals, providers, and agencies. The company has ...
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) ...
Bernd Muehlenweg, Ph.D., Senior Vice President, Head of Global Business Development, Cell Therapy, Evotec; Non-Executive Director, Sernova Vlad Seitan, Ph.D., Chief ...